SDHB
Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
Also known as: SDH, SDH1, SDHB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21912
- Gene
- SDHB
- Ensembl
- ENSG00000117118
- Chromosome
- 1
- Canonical length
- 280 aa
- Protein class
- Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Plasma membrane,Mitochondria
OverviewNCBI Gene
This tumor suppressor gene encodes the iron-sulfur protein subunit of the succinate dehydrogenase (SDH) enzyme complex which plays a critical role in mitochondria. The SDH enzyme complex is composed of four nuclear-encoded subunits. This enzyme complex converts succinate to fumarate which releases electrons as part of the citric acid cycle, and the enzyme complex additionally provides an attachment site for released electrons to be transferred to the oxidative phosphorylation pathway. The SDH enzyme complex plays a role in oxygen-related gene regulation through its conversion of succinate, which is an oxygen sensor that stabilizes the hypoxia-inducible factor 1 (HIF1) transcription factor. Sporadic and familial mutations in this gene result in paragangliomas, pheochromocytoma, and gastrointestinal stromal tumors, supporting a link between mitochondrial dysfunction and tumorigenesis. Mutations in this gene are also implicated in nuclear type 4 mitochondrial complex II deficiency. [provided by RefSeq, Jun 2022]
Canonical amino-acid sequenceUniProt
280 residues, UniProt reviewed canonical sequence.
>P21912|SDHB
1 MAAVVALSLR RRLPATTLGG ACLQASRGAQ TAAATAPRIK KFAIYRWDPD KAGDKPHMQT
61 YEVDLNKCGP MVLDALIKIK NEVDSTLTFR RSCREGICGS CAMNINGGNT LACTRRIDTN
121 LNKVSKIYPL PHMYVIKDLV PDLSNFYAQY KSIEPYLKKK DESQEGKQQY LQSIEEREKL
181 DGLYECILCA CCSTSCPSYW WNGDKYLGPA VLMQAYRWMI DSRDDFTEER LAKLQDPFSL
241 YRCHTIMNCT RTCPKGLNPG KAIAEIKKMM ATYKEKKASVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SDHB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 542 nTPM
Expression across tissuesHPA
Tissue
- tongue: 542 nTPM
- skeletal muscle: 461 nTPM
- heart muscle: 328 nTPM
- liver: 314 nTPM
- kidney: 212 nTPM
- duodenum: 153 nTPM
Single-cell type
- late primary spermatocytes: 349 nCPM
- enterocytes: 308 nCPM
- parietal cells: 286 nCPM
- esophageal basal cells: 277 nCPM
- hepatocytes: 271 nCPM
- esophageal suprabasal cells: 258 nCPM
Immune cell
- intermediate monocyte: 207 nTPM
- myeloid DC: 187 nTPM
- non-classical monocyte: 186 nTPM
- neutrophil: 175 nTPM
- classical monocyte: 150 nTPM
- eosinophil: 150 nTPM
Brain region
- choroid plexus: 84 nTPM
- cerebellum: 82 nTPM
- white matter: 76 nTPM
- hypothalamus: 75 nTPM
- medulla oblongata: 70 nTPM
- thalamus: 70 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SDHB.
Disease | AllUniProt
Conditions SDHB is implicated in, by any mechanism.
- Pheochromocytoma/paraganglioma syndrome 4 (PPGL4) MIM:115310
- Paraganglioma and gastric stromal sarcoma (PGGSS) MIM:606864
- Mitochondrial complex II deficiency, nuclear type 4 (MC2DN4) MIM:619224
Disease | GeneticClinVar
298 pathogenic / likely-pathogenic of 1,645 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pheochromocytoma/paraganglioma syndrome 4
- Gastrointestinal stromal tumor
- Pheochromocytoma
- Hereditary cancer-predisposing syndrome
- Hereditary pheochromocytoma and paraganglioma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.1
- DepMap mean gene effect
- -0.46
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial electron transport, succinate to ubiquinone
- proton motive force-driven mitochondrial ATP synthesis
- respiratory electron transport chain
- succinate metabolic process
- tricarboxylic acid cycle
Molecular functions
- 2 iron, 2 sulfur cluster binding
- 3 iron, 4 sulfur cluster binding
- 4 iron, 4 sulfur cluster binding
- electron transfer activity
- metal ion binding
- succinate dehydrogenase (quinone) activity
- ubiquinone binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 2Fe-2S ferredoxin-type iron-sulfur binding domain
- 2Fe-2S ferredoxin, iron-sulphur binding site
- Alpha-helical ferredoxin
- Beta-grasp domain superfamily
- 4Fe-4S ferredoxin-type, iron-sulphur binding domain
- 4Fe-4S ferredoxin, iron-sulphur binding, conserved site
- 2Fe-2S ferredoxin-like superfamily
- Succinate dehydrogenase/fumarate reductase iron-sulphur protein
- Succinate dehydogenase/fumarate reductase N-terminal
- Succinate Dehydrogenase/Fumarate Reductase Iron-Sulfur
- 2Fe-2S iron-sulfur cluster binding domain
- 4Fe-4S dicluster domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SDHB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SDHB as an antibody target. Whether an autoantibody or antibody against SDHB could matter depends on whether native SDHB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SDHB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SDHB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...